Stock Information for ABUS

Overview of ABUS

ABUS, also known as Arbutus Biopharma Corp, is a company in the Health Care sector. Arbutus Biopharma Corp's website is http://www.arbutusbio.com.

Market Capitalization

ABUS has a market cap of $712.49 million with 189,491,685.00 shares outstanding as of Tue, Nov 5, 2024.

Stock Charts

The ABUS stock charts offer a comprehensive, real-time view of Arbutus Biopharma Corp's stock performance. Powered by TradingView, these interactive charts provide investors with a dynamic and detailed visualization of ABUS's market activity.

Key features of the ABUS stock charts include:

• Real-Time Data: Get up-to-the-minute updates on Arbutus Biopharma Corp's stock price, ensuring you have the latest information at your fingertips.
• Customizable Time Frames: Analyze ABUS's performance over various periods, from intraday movements to long-term trends. Easily switch between daily, weekly, monthly, and yearly views.
• Technical Indicators: Utilize a wide array of technical indicators, such as moving averages, RSI, MACD, and more, to perform in-depth analysis of ABUS's stock movements.
• Drawing Tools: Enhance your analysis with TradingView's extensive drawing tools. Add trend lines, channels, Fibonacci retracements, and other annotations to your charts.
• Comparative Analysis: Compare ABUS's performance against other stocks, indices, or financial instruments to gain a broader market perspective.
• User-Friendly Interface: The interactive nature of the charts allows you to zoom in, pan across different periods, and hover over data points for detailed information, making it easy to track and analyze ABUS's stock performance.

Whether you're a day trader looking for quick insights or a long-term investor analyzing market trends, the ABUS stock charts provide all the tools you need to make informed decisions. Dive into the data and explore how Arbutus Biopharma Corp is performing in the market today.

Comprehensive Stock Forecast for ABUS

Understanding the future trajectory of a stock is crucial for investors, and ABUS is no exception. With numerous analysts and financial experts weighing in, it’s essential to have a comprehensive overview of what to expect. Below, we explore various aspects of the ABUS stock forecast, drawing insights from different time frames and sources to provide a well-rounded perspective.

The forecast for ABUS extends through multiple years, with detailed projections for 2024, 2025, 2029, 2034, and even as far as 2034. These projections are based on various factors, including market trends, financial health, and overall economic conditions. Notable sources such as FintechZoom, CNN Money, Zacks, and WalletInvestor offer diverse viewpoints, ensuring that investors get a holistic understanding of the potential growth or decline of ABUS.

In the short term, predictions for ABUS in the upcoming months or years (2024, 2025, 2029) are often influenced by current market performance and recent financial reports. For the long term, forecasts for 2029, 2034, and beyond consider broader economic indicators and industry trends. Analysts also provide specific outlooks, like the 5-year forecast, to help investors plan their strategies accordingly.

Moreover, platforms like CNBC and Yahoo Finance provide detailed analysis and expert opinions that contribute significantly to the stock’s forecast. Whether you’re looking for tomorrow’s prediction or the long-term outlook, these insights are invaluable. By examining forecasts from various credible sources, investors can make informed decisions based on a well-rounded view of the potential future of ABUS.